Andere talen Vivos Inc.

Aandelen

RDGL

US92858K2042

Beurs gesloten - OTC Markets Andere beurzen 21:59:59 29-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,157 ^USD	+4,67%		+47,42%	+117,15%

18/03	Vivos Inc. Rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	Vivos Inc. Kondigt aan dat Radiogel(TM) Precisie Radionuclide Therapie(TM) het predikaat Breakthrough Device van de FDA ontvangt	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation	20/12
Vivos Inc. Announces Radiogel(TM) Precision Radionuclide Therapy(TM) Receives FDA Breakthrough Device Designation	20/12
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11
Vivos : Quarterly Progress Report - Form 8-K	11-10-23
Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics	07-08-23
Vivos Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04-08-23
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	04-05-23
Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	04-05-23
VIVOS INC : Unregistered Sale of Equity Securities (form 8-K)	02-05-23
VIVOS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	01-03-23
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01-03-23
Vivos Inc. Auditor Raises 'Going Concern' Doubt	01-03-23
Vivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapy	11-01-23
Vivos Inc Files A New Patent on Alternate Particles for Precision Radionuclide Therapy	11-01-23
Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment	03-01-23
Vivos Inc. Files New Patent on Precision Radionuclide Therapy Support System Equipment	03-01-23
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	19-10-22
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	19-10-22
Vivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel™	14-09-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Vivos Inc.

Aandelen

RDGL

US92858K2042

Andere talen

Filters